Neoproteomics is a Uppsala-based biotechnology company developing a next-generation sequencing system for cancer diagnostics using biomarkers from platelets.
Neoproteomics is a Uppsala-based biotechnology company developing a next-generation sequencing system for cancer diagnostics using biomarkers from platelets.
Neoproteomics is a Uppsala-based biotechnology company developing a next-generation sequencing system for cancer diagnostics using biomarkers from platelets.